Trial Information
Inclusion Criteria:
- Women seeking for tubal sterilisation
Exclusion Criteria:
- women older than 45
- family history of ovarian cancer
- presence of menopausal symptoms
- irregular cycles
- Hormone Replacement Therapy or hormone contraceptions the last 3 months
- history of previous ovarian or uterine surgeries
- imaging suggesting an ovarian cyst or other adnexal pathology during investigation
- previous salpingectomy
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Outcome Measure:
Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)
Outcome Time Frame:
3 months
Safety Issue:
Yes
Authority:
Sweden: Regional Ethical Review Board
Study ID:
SEvsTSinAMH
NCT ID:
NCT01888159
Start Date:
September 2013
Completion Date:
Related Keywords:
- Ovarian Cancer
- Ovarian Neoplasms